[Clinico-immunological characteristics of drug allergy in patients with pulmonary tuberculosis]. 1991

B M Pukhlik, and V Mzaiĕk, and S V Zaikov

UI MeSH Term Description Entries
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

B M Pukhlik, and V Mzaiĕk, and S V Zaikov
January 1986, Problemy tuberkuleza,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
January 1993, Problemy tuberkuleza,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
April 1991, Vrachebnoe delo,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
January 1966, Problemy tuberkuleza,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
October 1985, Vestnik dermatologii i venerologii,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
January 1987, Problemy tuberkuleza,
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
August 1989, Kekkaku : [Tuberculosis],
B M Pukhlik, and V Mzaiĕk, and S V Zaikov
May 1989, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!